AI Model Virchow Revolutionizes Rare Cancer Detection
Virchow, developed by Paige, detects rare cancers with 94% accuracy, transforming cancer diagnosis and patient outcomes.
- Latest
- Trending
Virchow, developed by Paige, detects rare cancers with 94% accuracy, transforming cancer diagnosis and patient outcomes.
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.